EANM Guideline on Quality Risk Management for radiopharmaceuticals

Gillings, Nic; Hjelstuen, Olaug; Behe, Martin; Decristoforo, Clemens; Elsinga, Philip; Ferrari, Valentina; Kiß, Oliver; Kolenc, Petra; Koziorowski, Jacek; Laverman, Peter; Mindt, Thomas; Ocak, Meltem; Patt, Marianne; Todde, Sergio; Walte, Almut

doi:10.1007/s00259-022-05738-4

EANM Guideline on Quality Risk Management for radiopharmaceuticals

Gillings, N.; Hjelstuen, O.; Behe, M.; Decristoforo, C.; Elsinga, P.; Ferrari, V.; Kiß, O.; Kolenc, P.; Koziorowski, J.; Laverman, P.; Mindt, T.; Ocak, M.; Patt, M.; Todde, S.; Walte, A.

This document is intended as a supplement to the EANM “Guidelines on current Good Radiopharmacy Practice (cGRPP)” issued by the Radiopharmacy Committee of the EANM [1]. The aim of the EANM Radiopharmacy Committee is to provide a document that describes how to manage risks associated with small-scale “in-house” preparation of radiopharmaceuticals, not intended for commercial purposes or distribution.

Keywords: Risk assessment; radiopharmaceuticals; quality assurance

European Journal of Nuclear Medicine and Molecular Imaging 49(2022), 3353-3364
Online First (2022) DOI: 10.1007/s00259-022-05738-4
Cited 9 times in Scopus

Permalink: https://www.hzdr.de/publications/Publ-33561